Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. [electronic resource]
Producer: 20171004Description: 1173-1186 p. digitalISSN:- 1179-2027
- Biological Products -- administration & dosage
- Biosimilar Pharmaceuticals -- administration & dosage
- Drug Design
- Drug Industry -- economics
- Drugs, Generic -- economics
- Economic Competition
- Erythropoietin -- administration & dosage
- Europe
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Japan
- Linear Models
- Models, Economic
- Patents as Topic
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.